Maplelane Capital’s Madison Square Garden MSGS Stock Holding History
Bought
Maintained
Sold
Other funds holding MSGS
SLG
AI
SAM
GI
GF
Maplelane Capital's MSGS Position: Q3 2022 in Review
Maplelane Capital sold out of Madison Square Garden (MSGS) in Q3 2022, closing a stake of 28,200 shares — an estimated $4.26M sold.
Maplelane Capital first reported a position in MSGS in Q2 2013 and held it in 22 quarters. The position peaked at $40.5M in Q4 2020. 258 funds tracked by Wall St. Rank hold MSGS as of Q3 2022.
- Maplelane Capital reported no remaining Madison Square Garden position as of Q3 2022 after selling out during the quarter.
- Maplelane Capital sold 28,200 Madison Square Garden shares in Q3 2022, an estimated $4.26M.
- Maplelane Capital first reported a position in Madison Square Garden in Q2 2013 and held it in 22 quarters.
- Maplelane Capital's Madison Square Garden position peaked at $40.5M in Q4 2020.
- 258 funds tracked by Wall St. Rank held Madison Square Garden as of Q3 2022.
Based on Maplelane Capital's 13F filing for Q3 2022, filed 14 Nov 2022.